U.S. senator investigates FDA's actions.
BioNTech founders to establish a new company.
Focus on mRNA technology for future vaccines.
Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.
U.S. senator investigates FDA's actions.
BioNTech founders to establish a new company.
Focus on mRNA technology for future vaccines.